Patent US4710384A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4710384A Expired / Lapsed US ⏱️ 0.0 years remaining

Sustained release tablets made from microcapsules

Assignee: Bio Dar Ltd
•
Filing: 1986-07-28
•
Granted: 1987-12-01
•
Expires: 2006-07-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A tablet for oral adminstration of a sustained-release medication is formed by compressing microcapsules of the active principle. The microcapsules are of a size range between about 5 and 300 microns and comprise particles of active principle coated with a thin, flexible layer of sustained release material. The sustained-release material contains about 15-30% by weight thereof of plasticizer and is coated in an amount corresponding to 10-25% of the weight of the active material. Excipients causing disintegration of the tablet after administration can be uniformly mixed with the microcapsules prior to compression.

Inventors

  • 👤 Avner Rotman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 17:21
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/20; A61K9/2072; A61K9/2077; A61K9/2081; A61K9/0002; A61K9/0007

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 116 words
A new sustained release galenical form in the form of a disintegratable tablet, comprising compressed microcapsules of active principle and a pharmaceutically acceptable excipient interspersed among and throughly mixed with said microcapsules, wherein said microcapsules have a size range distributed between about 5 and about 300 microns and comprise particles of active principle coated with an encapsulating layer of an ethyl cellulose or acrylic resin sustained release polymer containing a sufficient amount of plasticizer to render said coating flexible, said amount being within the range of about 15 to about 30% of the weight of said sustained release polymer, said coating being no thicker than that which forms 25% of the weight of the active principle.
Claim 2
Dependent Claim 116 words
A new sustained release galenical form in the form of a disintegratable tablet, comprising compressed microcapsules of active principle and a pharmaceutically acceptable excipient interspersed among and throughly mixed with said microcapsules, wherein said microcapsules have a size range distributed between about 5 and about 300 microns and comprise particles of active principle coated with an encapsulating layer of an ethyl cellulose or acrylic resin sustained release polymer containing a sufficient amount of plasticizer to render said coating flexible, said amount being within the range of about 15 to about 30% of the weight of said sustained release polymer, said coating being no thicker than that which forms 25% of the weight of the active principle.
Claim 3
Dependent Claim 22 words
A galenical form in accordance with claim 1, wherein said excipient includes a material for causing disintegration of the tablet after administration.
Claim 4
Dependent Claim 27 words
A galenical form in accordance with claim 1, wherein said plasticizer is present in an amount of about 15-20% of the weight of said sustained release polymer.
Claim 5
Dependent Claim 23 words
A galenical form in accordance with claim 1, wherein said microcapsules have a size range distributed between about 30 and about 250 microns.
Claim 6
Dependent Claim 32 words
A galenical form in accordance with claim 1, wherein said sustained release polymer is coated on said active principle in an amount corresponding to 10-25% of the weight of the active material.
Claim 7
Dependent Claim 29 words
A galenical form in accordance with claim 5, wherein said sustained release polymer is coated on said active principle in an amount corresponding to 15-20% of said active material.

References Cited (Backward Citations)

US3325365A Cited
US3341416A Cited
US3400185A Cited
US3495988A Cited
US4016254A Cited
US3860733A Cited
US3922338A Cited
US4113816A Cited
US3911099A Cited
US4316884A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-11-30 1991-06-01 1991-12-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-11-30 1995-06-01 1995-12-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-11-30 1999-06-01 1999-12-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag